Communiqués Brain Scientific Inc.

Actions

BRSF

US10488W2089

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets 15:52:19 13/05/2026			Varia. 5j.	Varia. 1 janv.
0,000600 ^USD	+500,00%		-.--%	+500,00%

01/05/23	Brain Scientific Inc. (OTCPK:BRSF) a annulé l'acquisition d'IMAC Holdings, Inc. (NasdaqCM:BACK).	CI
31/03/23	Brain Scientific Inc. publie ses résultats pour l'exercice clos le 31 décembre 2022	CI

Communiqués

05/04/23	Brain Scientific : Material Agreement - Form 8-K	PU
20/03/23	IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution	AQ
28/02/23	Brain Scientific Sees Increased First-Quarter Sales Momentum and Revenue Growth	GL
23/02/23	Life After PTSD and Brain Scientific Form Collaboration to Tackle PTSD	GL
16/02/23	MVAP Medical Supplies Submits Major Order for NeuroCaps, Sees Huge Opportunity in Pediatrics	GL
06/02/23	Brainbox Validates NeuroCap(TM) In Testing Regimen; Adds Them to its Sports Medicine and Pharma Solutions	GL
26/01/23	Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel	GL
26/01/23	Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel	AQ
03/01/23	BRAIN SCIENTIFIC INC. : Change in Directors or Principal Officers (form 8-K)	AQ
15/12/22	Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space	GL
15/12/22	Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space	AQ
01/12/22	Brain Scientific Inks Deal with Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications	GL
01/12/22	Brain Scientific Inks Deal with Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications	AQ
15/11/22	Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical	GL
14/11/22	BRAIN SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
03/11/22	BRAIN SCIENTIFIC INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/11/22	Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer	GL
01/11/22	Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer	AQ
24/08/22	Brain Scientific Announces CE Mark Approval for NeuroCap™ Device	GL
24/08/22	Brain Scientific Announces CE Mark Approval for NeuroCap™ Device	GL
15/08/22	BRAIN SCIENTIFIC INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
15/06/22	Brain Scientific : Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants; Converts Approximately $12.9 Million of Existing Debt into Equity - Form 8-K	PU
15/06/22	BRAIN SCIENTIFIC INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
15/06/22	Brain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity	GL
15/06/22	Brain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity	AQ